D2L Clinical Solutions
India‑based CRO delivering fast, compliant, and cost‑effective clinical trial execution across multiple therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based CRO delivering fast, compliant, and cost‑effective clinical trial execution across multiple therapeutic areas.
OncologyCardiologyNeurologyGastroenterologyImmunologyHerbal MedicineNutraceuticals
Technology Platform
A centralized operational model combined with a digital health suite for electronic data capture, remote monitoring, and real‑time analytics to streamline multi‑site clinical trials.
Opportunities
Rapid growth of India’s clinical research market and increasing demand for decentralized trial technologies offer D2L significant expansion potential.
Risk Factors
Regulatory changes, intense competition from larger global CROs, and the need for continual technology investment pose key risks.
Competitive Landscape
Competes with Indian CROs such as Syngene International, QuintilesIMS, and Global CROs; differentiation lies in its centralized operational model and integrated digital health platform.